Pandemenza
INTRODUZIONE
PARTE I
3
, Post del blog viaggiepianoforte sulla Cina e sulla sezione impervia di Jiankou della Grande Muraglia.
4
, Italia capofila delle strategie vaccinali a livello mondiale. Comunicato AIFA N. 387. 29 Settembre 2014 (254.7 KB)
5
et alias, Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. JAMA Network Open, Dicembre 2021 (1.4 MB)
6
, Primo report Covid-19 dell’Istituto Superiore di Sanità. 6 Aprile 2020 (150.9 KB)
7
Atto di denuncia Cipolloni Stefano Vs governo Mario Draghi. Marzo 2022 (328.7 KB)
8
Lacrimogeni ed idranti sui manifestanti a Trieste. 18 Ottobre 2021
9
, L’altra epidemia. Rivista di psichiatria, 9 Marzo 2022 (74.7 KB)
10
, COVID-19: stigmatising the unvaccinated is not justified. The Lancet, Novembre 2021 (136.7 KB)
11
, «Non si vaccinano devo proteggere le mie bambine»: il Natale degli italiani con i parenti No vax. Dicembre 2021 (279.3 KB)
12
, Post del blog viaggiepianoforte sul genocidio rwandese.
13
, Ai confini dell'umanità: i No-Vax. 9 Ottobre 2021
14
, Sentenza N. 1842. 17 Febbraio 2022 (1.5 MB)
15
, Rapporto AIFA sorveglianza vaccini Covid-19 N.9 - periodo dal 27/12/2020 al 26/09/2021. (1.3 MB)
16
et alias, Impact of Covid-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders, Agosto 2020 (723.7 KB)
17
et alias, Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries. The Lancet, Maggio 2022 (842.7 KB)
18
et alias, The impact of COVID‑19 lockdown on child and adolescent mental
health: systematic review. European Child & Adolescent Psychiatry, Luglio 2021 (679.6 KB)
19
et alias, COVID-19 lockdown effects on adolescent brain structure suggest accelerated maturation that is more pronounced in females than in males. PNAS, Luglio 2024 (1.7 MB)
PARTE II
20
et alias, Who funds the WHO Foundation? A transparency analysis of donation disclosures over the first 3 years of its operation. The British Medical Journal, Gennaio 2025 (1 MB)
21
, Standard per l’educazione sessuale in Europa. Dicembre 2011 (1.4 MB)
22
, et alias, Psychiatric Morbidity Among Adolescents and Young
Adults Who Contacted Specialised Gender Identity Services in Finland in 1996–2019: A Register Study. Acta Paediatrica, Aprile 2026 (227.7 KB)
23
, Post di viaggiepianoforte sul Burkina Faso ed il neocolonialismo.
24a
, Sentenza Consulta N. 185. 5 Ottobre 2023 (62.2 KB)
24b
, Sentenza Consulta N.199. 23 Dicembre 2025 (115.2 KB)
25
, , Volantini "Vacciniamoci" e "Sì al vaccino, Sì alla vita". (458.7 KB)
26
, Lettera aperta della OSA Polizia sulla vertenza inerente gli effetti avversi da vaccino, 17/05/2024. 17 Maggio 2024 (539.2 KB)
27
Il punto più basso della pandemia in Italia, la canzone natalizia di Bassetti, Crisanti e Pregliasco.
28
Dichiarazione ICMJE Matteo Bassetti sul conflitto d’interesse. (498.1 KB)
29
La coerenza di Matteo Bassetti.
30a
Il nobel Giorgio Parisi riceve la terza dose.
30b
Spot di Giorgio Parisi sulla 4a dose.
31
, The EMA Covid-19 data leak, and what it tells us about mRNA instability. The British Medical Journal, Marzo 2021 (581.6 KB)
32
, Morte "naturale" nei giovani.
33
, Post del blog viaggiepianoforte sulla Cristiada messicana.
34
, Post del blog viaggiepianoforte su Thomas Sankara.
35
Prima uscita pubblica di Bergoglio.
36
Saluto tra massoni: Bergoglio omaggia Napolitano.
37
, Post del blog viaggiepianoforte sulla Valle di Kathmandu in Nepal.
38
, Post del blog viaggiepianoforte sulla Santa Muerte messicana.
39
et alias, Attenuation of RA 2713 Rubella Virus in WI-38 Human Diploid Cells. The American Journal of Diseases of Children, Agosto 1969 (102.4 KB)
40
et alias, Characteristics of a Human Diploid Cell Designated MRC-5. Nature, Luglio 1970 (1 MB)
41
et alias, Characteristics and viral propagation properties of a new human diploid cell line, walvax-2, and its suitability as a candidate cell substrate for vaccine production. Human Vaccines & Immunotherapeutics, Aprile 2015 (876.7 KB)
42
, COVID Vaccines & Fetal Cell Lines. Febbraio 2021 (1.4 MB)
43
, Documento di sintesi per Renovatio21: Vaccini e linee cellulari di feti abortiti. (612.8 KB)
44a
et alias, Time Spent on Social Media and Risk of Depression in Adolescents: A Dose–Response Meta-Analysis. International Journal of Environmental Research and Public Health, Aprile 2022 (1.3 MB)
44b
et alias, The Use of Social Media in Children and Adolescents: Scoping Review on the Potential Risks. International Journal of Environmental Research and Public Health, Agosto 2022 (953.7 KB)
45
, The Euro area adjustment: about halfway there. Europe Economic Research, Maggio 2013 (322 KB)
46a
, Post del blog viaggiepianoforte su Raja Ampat in Indonesia.
46b
, Post del blog viaggiepianoforte sugli squali balena indonesiani.
PARTE III
Cap 3.1
47
et alias, Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. The New England Journal of Medicine, Novembre 2021 (642.1 KB)
48
, , Ghostwriting: Research Misconduct, Plagiarism, or Fool’s Gold? The American Journal of Medicine, Aprile 2012 (164.3 KB)
49
, Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature. The British Medical Journal, Giugno 2024 (1.6 MB)
50
, Nonfinancial conflict of interest in peer-review: Some notes for discussion. Accountability in Reserch, Giugno 2023 (328.2 KB)
51
, Peer review: a flawed process at the heart of science and journals. Journal of the Royal Society of Medicine, Aprile 2026 (63.6 KB)
52
, How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data. PloS ONE, Maggio 2009 (327.3 KB)
53
et alias, Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BioMed Central, Dicembre 2008 (233.1 KB)
54
, Offline: What is medicine’s 5 sigma? The Lancet, Aprile 2015 (262.4 KB)
55
, False individual patient data and zombie randomised controlled trials submitted to Anaesthesia. Anaesthesia, 2021/76/472–479 (130.6 KB)
56
, Hundreds of thousands of zombie randomised trials circulate among us. Anaesthesia, 2021/76/444–447 (49.4 KB)
57
, Why most published research findings are false. PLoS Medicine, Agosto 2005 (249.6 KB)
58
, , The illusion of evidence based medicine. The British Medical Journal EBM, Marzo 2022 (141.1 KB)
59
, The codex of science: honesty, precision, and truth - and its violations. European Heart Journal, Febbraio 2013 (258.6 KB)
60
, , , The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias. The British Medical Journal EBM, Aprile 2020 (241.1 KB)
61
, , EMA’s mishandling of an investigation into suspected serious neurological harms of HPV vaccines. The British Medical Journal EBM, Febbraio 2022 (174.8 KB)
62
, , , Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports. BioMed Central, Febbraio 2020 (1.4 MB)
63
“Inventori di malattie” - Documentario di Silvestro Montanaro.
64
et alias, Relationship between authors of clinical practice guidelines and the pharmaceutical industry. JAMA, Febbraio 2022 (808.7 KB)
65
et alias, Projected Lifetime Cancer Risks From Current Computed Tomography Imaging. JAMA Internal Medicine, Aprile 2025 (508.3 KB)
66
et alias, Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk. The New England Journal of Medicine, Settembre 2025 (630.5 KB)
Cap 3.2
67
, Our prescription drugs kill us in large numbers. Controversies in Medicine, Ottobre 2014 (196.1 KB)
68
, Medical error: the third leading cause of death in the US. The British Medical Journal, Maggio 2016 (1.1 MB)
69
Trailer della serie tv “Dopesick”.
70
Trailer della serie tv “PainKiller”.
71
“Cavie umane” – Documentario di Stefano Liberti.
72
et alias, Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. The British Medical Journal, Aprile 2014 (852.4 KB)
Cap 3.3
73
, The Cutter Incident: How America’s First Polio Vaccine Led to the Growing Vaccine Crisis. The British Medical Journal, Marzo 2006 (84.2 KB)
74
, The polio vaccine: a critical assessment of its arcane history, efficacy, and long-term health related consequences. Medical Veritas, (2004) 239-251 (498.7 KB)
75
Sentenza N. 34027 su danno da vaccino anti polio. Corte suprema di Cassazione, III sez. civile, 8 Giugno 2022 (1.3 MB)
76
et alias, Correlation between Non-Polio Acute Flaccid Paralysis rates with pulse polio frequency in India. International Journal of Environmental Research and Public Health, Agosto 2018 (766 KB)
77
How Bill Gates Funded NGO PATH Killed Tribal Girls In India In Unauthorised Clinical Trials.
78
et alias, Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. Journal of the Royal Society of Medicine, 2012 (1.4 MB)
79
, Report finale: "Alleged irregularities in the conduct of studies using Human Papilloma Virus (HPV) vaccine by PATH in India". 15 Febbraio 2011 (2.9 MB)
80
, Critique of World Health Organization Recommendation of a Dengue Vaccine. The Journal of Infectious Diseases, Agosto 2016 (168.2 KB)
81
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children. The New England Journal of Medicine, Ottobre 2011 (728 KB)
82
et alias, The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment. EbioMedicine, Febbraio 2017 (593.3 KB)
83
et alias, Evidence of Increase in Mortality After the Introduction of Diphtheria–Tetanus–Pertussis Vaccine to Children Aged 6–35 Months in Guinea-Bissau: A Time for Reflection? Frontiers in Public Health, Marzo 2018 (631.1 KB)
84
et alias, HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World. Open Access Library Journal, Ottobre 2017 (2.5 MB)
85
et alias, Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. The British Journal of Psychiatry, 2014 (159.3 KB)
86
et alias, Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet, Febbraio 1998 (942.1 KB)
87
, Autism and vaccines.
88
, A Positive Association found between Autism Prevalence and Childhood Vaccination uptake across the U.S. Population. Journal of Toxicology and Environmental Health, Maggio 2011 (745.3 KB)
89
, The history of vaccinations in the light of the autism epidemic. Alternative Therapies, Dicembre 2008 (447.3 KB)
90
, What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature? North American Journal of Medical Sciences, Luglio 2009 (746.5 KB)
91
et alias, Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism. Journal of Biomedical Science, Dicembre 2001 (1.1 MB)
92
, Theoretical aspects of autism: Causes - A review. Journal of Immunotoxicology, Dicembre 2010 (701.9 KB)
93
et alias, Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Annals of Internal Medicine, Marzo 2019 (200.4 KB)
94
et alias, Hviid et al 2019 Vaccine-Autism Study: Much Ado About Nothing? Journal of Biotechnology, Maggio 2025 (685.4 KB)
95
et alias, Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmunity Reviews, Febbraio 2023 (1.6 MB)
96
et alias, "SAIA" - Sindrome autoimmune/infiammatoria indotta da adiuvanti: presente e futuro. Reumatismo, Febbraio 2011 (657.1 KB)
97
et alias, A comprehensive review of mercury provoked autism. Indian Journal of Medical research, Ottobre 2008 (252.2 KB)
98
et alias, Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health and Place, 2006 (102.5 KB)
99
et alias, Autism: a novel form of mercury poisoning. Medical Hypotheses, 2001 (1.1 MB)
100
et alias, A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Translational Neurodegeneration, 2013 (223.7 KB)
101
et alias, Controversies surrounding mercury in vaccines: autism denial as impediment to universal immunisation. Indian Journal of Medical Ethics, Dicembre 2014 (65.1 KB)
102
et alias, A Case Series of Children with Apparent Mercury Toxic Encephalopathies Manifesting with Clinical Symptoms of Regressive Autistic Disorders. Journal of Toxicology and Environmental Health, Aprile 2007 (146.8 KB)
103
, The relationship between mercury and autism: A comprehensive review and discussion. Journal of Trace Elements in Medicine and Biology, Giugno 2016 (1.8 MB)
104
et alias, Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe. BioMed Research International, 2014 (578 KB)
105
et alias, B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal. Journal of Toxicology, 2013 (929.2 KB)
106
et alias, Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism. International Journal of Environmental Research and Public Health, Ottobre 2013 (285.4 KB)
107
et alias, Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environmental Health, 2025 (1.9 MB)
108
, Aluminum in Childhood Vaccines Is Unsafe. Journal of American Physicians and Surgeons, 2016 (605.3 KB)
109
, , Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunological Research, Aprile 2013 (578.9 KB)
110
, , Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Journal of Inorganic Biochemistry, Agosto 2011 (378 KB)
111
et alias, Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy, 2012 (440.9 KB)
112
, Retraction notice to“Safety evaluation and risk assessment of the herbicide roundup and its active ingredient, glyphosate, for humans” [Regul. Toxicol. Pharm. 31 (2000) 117–165]. Regulatory Toxicology and Pharmacology, 2025 (297.6 KB)
113
et alias, Genetically engineered crops, glyphosate and the deterioration of health in the United States of America. Journal of Organic Systems, 2014 (2.9 MB)
114
, , The Possible Link between Autism and Glyphosate Acting as Glycine Mimetic - A Review of Evidence from the Literature with Analysis. Molecular and Genetic Medicine, 2025 (1.3 MB)
115
, , Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases. Journal of Biological Physics and Chemistry, Marzo 2017 (651.4 KB)
116
et alias, Factors associated with underreporting of adverse drug reactions by patients: a systematic review. International Journal of Clinical Pharmacy, Maggio 2023 (1.2 MB)
117
, , Under-Reporting of Adverse Drug Reactions - A Systematic Review. Drug Safety, 2006 (221.3 KB)
118
, Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. Journal of the Royal Society of Medicine, Giugno 1991 (707.1 KB)
119
Sorveglianza degli effetti avversi a vaccini in Puglia - Report 2013/2017. Trimestrale dell’osservatorio epidemiologico regionale, Dicembre 2018 (3.8 MB)
120
, Electronic Support for Public Health - Vaccine Adverse Event Reporting System (ESP:VAERS) – Grant Final Report (ID: R18 HS 017045 ) (96.2 KB)
121
, Critical Appraisal of VAERS Pharmacovigilance: Is the U.S. Vaccine Adverse Events Reporting System (VAERS) a Functioning Pharmacovigilance System? Science, Public Health Policy and the Law, Ottobre 2021 (2.2 MB)
122
, , Case Study: Varicella Vaccine and the Suppression of Data. Journal of American Physicians and Surgeons, 2022 (64.5 KB)
123
et alias, Letter to the Editor - Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine, Maggio 2005 (64.6 KB)
124
, Vaccines and sudden infant death: An analysis of the VAERS database 1990–2019 and review of the medical literature. Toxicology Reports, Giugno 2021 (1.4 MB)
125
et alias, Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence. Cureus, Maggio 2022 (198 KB)
126
, , , Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2022. Journal of Toxicology and Environmental Health, Aprile 2010 (290 KB)
127
et alias, Pilot comparative study on the health of vaccinated and unvaccinated 6 to 12 year old U.S. children. Journal of Translational Science, 2017 (521.4 KB)
128
, , Health effects in vaccinated versus unvaccinated children, with covariates for breastfeeding status and type of birth. Journal of Translational Science, 2021 (512.2 KB)
129
, , Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders. SAGE Open Medicine, Aprile 2020 (589.2 KB)
130
, , Neonatal, Infant, and Under Age Five Vaccine Doses Routinely Given in Developed Nations and Their Association With Mortality Rates. Cureus, Luglio 2023 (489.7 KB)
131
, , Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity? Human and Experimental Toxicology, 2011 (246.6 KB)
132
, Health versus Disorder, Disease, and Death: Unvaccinated Persons Are Incommensurably Healthier than Vaccinated. International Journal of Vaccine Theory, Practice, and Research, Novembre 2022 (929.6 KB)
133a
et alias, Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder. Pediatrics, Settembre 2018 (1 MB)
133b
et alias, Maternal Gestational Tdap Vaccination and Autism: A Critique of Becerra-Culqui et al. (2018). International Journal of Vaccine Theory, Practice, and Research, Aprile 2022 (324.7 KB)
134
et alias, Impact of Childhood Vaccination on Short and Long-Term Chronic Health Outcomes in Children: A Birth Cohort Study. (268.2 KB)
135
, , Determinants of Autism Spectrum Disorder. McCullogh Fundation Report, 2025 (5.7 MB)
136
, , RETRACTED: Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination. International Journal of Environmental Research and Public Health, 2020 (2.3 MB)
137
Prospetto studi RCT con placebo dei vaccini raccomandati da CDC ed ammessi da FDA. ICAN (Informed Consent Action network) (367.4 KB)
138
et alias, Current Evidence About the Role of Animals in the Transmission of Sars-Cov-2: Implications for Public Health. Revista Lasallista de Investigación, Giugno 2022 (979.7 KB)
139
, The polio vaccine: a critical assessment of its arcane history, efficacy, and long-term health related consequences. Medical Veritas, 2004 (498.7 KB)
140
Scheda tecnica vaccino Nobivac rabbia per animali. (228.4 KB)
141
, Diffida ad adempiere all'AIFA. Luglio 2017 (1.5 MB)
142
, Relazione finale sui gravi problemi di salute dei militari italiani a causa dell’esposizione a contaminanti ambientali ed eccesso di vaccinazione. Atti parlamentari, XVII leg. Doc. XXII-bis N. 23 (3.5 MB)
Cap 3.4
143
, A Bayesian analysis concludes beyond a reasonable doubt that SARS-CoV-2 is not a natural zoonosis but instead is laboratory derived.
144
, Testimonianza al Senato degli Stati Uniti. 18 Giugno 2024 (600.7 KB)
145
et alias, MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site. Frontiers in Virology, Febbraio 2022 (561.4 KB)
146
, Punti dubbi su Fort Detrick (USAMRIID).
147
et alias, Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori Journal, 2021 (1.4 MB)
148
, Lockdown: per Goldman Sachs in Italia i danni economici più ampi. Male anche India e Cina.
149
et alias, Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants. The New England Journal of Medicine, Gennaio 2022 (953.4 KB)
150
, , Predictions from standard epidemiological models of consequences of segregating and isolating vulnerable people into care facilities. PloS ONE, Ottobre 2023 (2.6 MB)
151
et alias, Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19. European Journal of Clinical Investigation, 2021 (339.5 KB)
152
et alias, The Swedish COVID-19 approach: a scientific dialogue on mitigation policies. Frontiers in Public Health, Giugno 2023 (133.8 KB)
153
, Sweden during the Pandemic: Pariah or Paragon? CATO Policy Analysis, Agosto 2023 (397 KB)
154
et alias, Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates. Clinical Infectious Diseases, 2021 (412.3 KB)
155
, Tamponi... anali!
156
et alias, Physical interventions to interrupt or reduce the spread of respiratory viruses (Review). Cochrane Library, 2020 (2.3 MB)
157
et alias, Child mask mandates for COVID-19: a systematic review. The British Medical Journal, Dicembre 2023 (551.9 KB)
158
, The Foegen effect - A mechanism by which facemasks contribute to the COVID-19 case fatality rate. Medicine, 2022 (545.9 KB)
159
, Inhaled CO2 Concentration While Wearing Face Masks: A Pilot Study Using Capnography. Environmental Health Insights, 2022 (684.1 KB)
160
, Ultimo rapporto - Caratteristiche dei pazienti deceduti positivi all’infezione da SARS
CoV 2 in Italia. 10 Gennaio 2022 (2.5 MB)
161
et alias, Microbiologically confirmed infections and antibiotic‑resistance in a national surveillance study of hospitalised patients who died with COVID‑19, Italy 2020–2021. Antimicrobial Resistance & Infection Control, 2022 (1 MB)
162
et alias, Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19. The Journal of Clinical Investigation, 2023 (7.4 MB)
163
et alias, Deaths “due to” COVID-19 and deaths “with” COVID-19 during the Omicron variant surge, among hospitalized patients in seven tertiary-care hospitals, Athens, Greece. Nature, 2025 (1.3 MB)
164
et alias, Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons). International Journal of Infectious Diseases, 2019 (946.9 KB)
165
, CovidStat.
166
, Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial. The British Medical Journal, Novembre 2021 (570.2 KB)
167
, et alias, Transparency of COVID-19 vaccine trials: decisions without data. The British Medical Journal EBM, 2021 (349 KB)
168
, The conundrum of current anti-SARS-CoV-2 vaccines. Cytokine and Growth Factor Reviews, Marzo 2021 (494.4 KB)
169
, Report 5.3.6. Comunaltive Analysis of post-authorization adverse event reports of PF-07302048 (BNT162B2) received through 28-feb 2021. Aprile 2021 (983.6 KB)
170
, Appendix 2.2: Cumulative and interval summary tabulation of serious and non-serious adverse reactions from post-marketing data sources. Giugno 2022 (4.2 MB)
171
, Covid, chi sceglie di non vaccinarsi può mettere a rischio anche i vaccinati – Lo studio. 27 Aprile 2022
172
et alias, Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens. PLOS Biology, Luglio 2015 (917.7 KB)
173
et alias, Imperfect vaccines and the evolution of pathogen virulence. Nature, Dicembre 2001 (178.6 KB)
174
et alias, Risk of rapid evolutionary escape from biomedical interventions targeting SARS CoV-2 spike protein. PloS ONE, Aprile 2021 (1.8 MB)
175
et alias, Emerging vaccine-breakthrough SARS-CoV-2 variants. ACS Infectious Diseases, Settembre 2023 (2.4 MB)
176
, , Anticipating and Identifying Collateral Damage in Genome Editing. Trends in genetics, Dicembre 2020 (877.9 KB)
177
et alias, Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada. Autoimmunity, 2025 (8.6 MB)
178
, , Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty. Methods and Protocols, Maggio 2024 (1.2 MB)
179
et alias, BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence. Science, Public Health Policy and the Law, Dicembre 2024 (1.1 MB)
180
et alias, Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Current Issues in Molecular Biology, Febbraio 2022 (2.4 MB)
181
et alias, Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. PNAS, Maggio 2021 (873.1 KB)
182
, Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines? Virus Research, Maggio 2021 (1.8 MB)
183
, mRNA Vaccines: Why Is the Biology of Retroposition Ignored? Genes, Aprile 2022 (1.1 MB)
184
, , The mRNA-LNP vaccines – the good, the bad and the ugly? Frontiers in immunology, Febbraio 2024 (2.2 MB)
185
, Some Differences Between RNA-based Vaccines and RNA-viral Infections and Immune Reactivity. Journal of Biology and Life Science, Febbraio 2025 (1.1 MB)
186
, , Potential health risks of mRNA-based vaccine therapy: A hypothesis. Medical Hypotheses, Gennaio 2023 (1.1 MB)
187
Jesse Gelsinger, la prima vittima ufficiale della storia di terapie geniche.
188
, Il Prof. Burioni spiega perché i vaccini sono sicuri e non dobbiamo temere presunti effetti a lungo termine. 5 Novembre 2021
189
, , , Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population. Pathogens, Febbraio 2023 (439.5 KB)
190
et alias, Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients. NPJ Vaccines, 2023 (4.6 MB)
191
et alias, Detection of Pfizer BioNTech Messenger RNA COVID-19 Vaccine in Human Blood, Placenta and Semen. Annals of Case Reports, Ottobre 2025 (474.7 KB)
192
et alias, Biodistribution of mRNA COVID-19 vaccines in human breast milk. The Lancet, Settembre 2023 (1.3 MB)
193
et alias, The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nature Neuroscience, Marzo 2021 (5.3 MB)
194
et alias, The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier. Neurobiology of Disease, Ottobre 2020 (7.6 MB)
195
et alias, Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series. International Journal of Molecular Science, Giugno 2022 (2.2 MB)
196
, Studio num. 185350 su biodistribuzione della Spike – parte A. (1002.8 KB)
197
, Studio num. 185350 su biodistribuzione della Spike – parte B. (1.4 MB)
198
et alias, Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clinical Infectious Diseases, Maggio 2021 (780.6 KB)
199
et alias, Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination. Biomedicines, Giugno 2022 (2.4 MB)
200
et alias, SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination. Journal of Pathology, Microbiology and Immunology, 2023 (471.2 KB)
201
et alias, Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell, Marzo 2022
202
, , Delayed Fatal Pulmonary Hemorrhage Following Covid-19 Vaccination: Case Report, Batch Analysis, And Proposed Autopsy Checklist. International Journal of Innovative Research in Medical Science (IJIRMS), Febbraio 2025 (398.8 KB)
203
Allegato I: riassunto delle caratteristiche del prodotto Comirnaty di Pfizer. (3.2 MB)
204
Allegato I: riassunto delle caratteristiche del prodotto Spikevax di ModeRna. (2.1 MB)
205
Allegato I: riassunto delle caratteristiche del prodotto Vaxzevria di Astrazeneca. (670.2 KB)
206
Allegato I: riassunto delle caratteristiche del prodotto Jcovden di Janssen. (1.6 MB)
207
et alias, BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection, 2021 (349.2 KB)
208
La ricercatrice dell'ISS Loredana Fransca mette in guardia sulla sicurezza del vaccino anti-Covid.
209
, The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines. Vaccines, Novembre 2024 (1.1 MB)
210
, Studio di fase 2/3 per valutare efficacia e sicurezza del Comirnaty (BNT162b2) su donne incinte.
211
Il ministero della salute inglese sconsiglia la vaccinazione delle donne incinte.
212
et alias, Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. The New England Journal of Medicine, Aprile 2021 (487.6 KB)
213
et alias, Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky. The New England Journal of Medicine, Aprile 2021 (367.4 KB)
214
et alias, Transplacental transmission of the COVID-19 vaccine messenger RNA: evidence from placental, maternal, and cord blood analyses postvaccination. American Journal of Obstetrix and Gynecology, Giugno 2024
215
, Comparison of Adverse Events in Pregnant Persons Receiving COVID‑19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases. Drug Safety, Giugno 2025 (1.3 MB)
216a
, et alias, Increased risk of fetal loss after COVID-19 vaccination. Human Reproduction, Ottobre 2023 (525.6 KB)
216b
, et alias, COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function. Journal of American Physicians and Surgeons, 2023 (2.7 MB)
217
, COVID-19 Vaccinations and Pregnancy Outcomes - Testimonianza al Senato degli USA. (262.5 KB)
218
, Report del 05/10/2021: Caratteristiche dei pazienti deceduti positivi all’infezione da SARS-CoV-2 in Italia. (748.8 KB)
219
, OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents. Epidemiology, Gennaio 2026 (1.2 MB)
220a
Il ministro della morte Speranza parla della vaccinazione pediatrica.
220b
Propaganda televisiva per convincere le mamme a vaccinare i figli.
221
et alias, A focused protection vaccination strategy: why we should not target children with COVID-19 vaccination policies. Journal of Medical Ethics, 2021 (166.3 KB)
222
et alias, Serious Adverse Drug Reactions to COVID-19 Vaccines in the Pediatric Population: A Retrospective, Cross-Sectional Study Utilizing the Eudravigilance Database for the European Economic Area. Journal of Clinical Medicine, Settembre 2025 (395.4 KB)
223
et alias, Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals. Science Traslational Medicine, Luglio 2022 (599.5 KB)
224
et alias, A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection. Evaluation & the Health Professions, 2021 (177.5 KB)
225
et alias, Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. The New England Journal of Medicine, Dicembre 2021 (294.6 KB)
226
et alias, Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network. Clinical Infectious Diseases, Ottobre 2022 (740.8 KB)
227
et alias, Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nature Microbiology, Ottobre 2020 (1.7 MB)
228
et alias, Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management. Vaccine, Marzo 2023 (327.8 KB)
229
, Nota prot. N.0008284 sulla vaccinazione dei soggetti con immunità naturale già acquisita. 3 Marzo 2021 (361.5 KB)
230
L'Istituto Mario Negri esalta ciò che le case farmaceutiche vietano.
231
et alias, L'informazione statistica sui vaccini anti-COVID-19. Il caso Italia tra errori, mistificazioni e omissioni. Università degli Studi di Firenze - DISIA Working Paper, Ottobre 2025 (1.7 MB)
232
et alias, COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities. Journal of Medical Ethics, Dicembre 2022 (841.7 KB)
233
, The epidemiological relevance of the COVID-19-vaccinated population is
increasing. The Lancet Regional Health – Europe, Novembre 2021 (358.7 KB)
234
, , Increases in COVID‑19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. European Journal of Epidemiology, 2021 (896.9 KB)
235
et alias, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet, Ottobre 2021 (1.8 MB)
236
et alias, Behavioral and Health Outcomes of mRNA COVID-19 Vaccination: A Case-Control Study in Japanese Small and Medium-Sized Enterprises. Cureus, Dicembre 2024 (142.2 KB)
237
et alias, Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine. Open Forum Infectious Diseases, Aprile 2023 (703.7 KB)
238
et alias, Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers. Communications Medicine, 2025 (971.3 KB)
239
, Elementi di preparazione ed implementazione della strategia vaccinale. 24 Marzo 2021 (4.1 MB)
240
, Risposta all'associazione Arbitrium - Prot. 0094558. 19 Luglio 2024 (265.9 KB)
241
Ammissione al parlamento UE di Janine Small di Pfizer alla domanda dell'eurodeputato olandese Rob Ross.
242
, Il deputato europeo Rob Roos non sa a cosa servono i vaccini.
243
, le persone immunizzate non sono contagiose.
244
, Covid-19 vaccine trial protocols released. The British Medical Journal, Ottobre 2020 (440.5 KB)
245
, Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. The British Medical Journal, Ottobre 2020 (591.5 KB)
246
Decessi Covid 2021 e 2022 (biennio con vaccini) confrontati con anno 2020 (anno senza vaccini).
247
et alias, Classification bias and impact of COVID-19 vaccination on all-cause mortality: the case of the Italian region Emilia-Romagna. Autoimmunity, 2025 (2 MB)
248
, Presentazione al senato italiano - Covid-19: The illusion of efficacy and safety for vaccines and other interventions. 19 Aprile 2024 (2.3 MB)
249
, , , The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies. MedRxiv (studio in pre-print) (879.4 KB)
250
, Percentuale popolazione inglese non vaccinata.
251
, , All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”. International Journal of Vaccine Theory, Practice, and Research, Maggio 2022 (595.4 KB)
252
, , COVID-19 vaccines – An Australian Review. Journal of Clinical & Experimental Immunology, 2022 (508.3 KB)
253
, Perizia timbrata e firmata - Decessi in UK relazionati al Covid suddivisi per mese e stato vaccinale dal 04/2021 al 05/2023. (4.3 MB)
254
, , Did the COVID-19 vaccines save millions of lives in the USA? Quantitative assessment of published claims. Correlation Research in the Public Interest, Ottobre 2025 (1.9 MB)
255
et alias, Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet, Settembre 2022 (4.2 MB)
256
et alias, Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study. The Lancet, Settembre 2024 (922.6 KB)
257
et alias, Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020-2024. JAMA Health Forum, 2025 (770.7 KB)
258
, False that 1-4M lives saved by COVID-19 vaccination during 2020-2024. Correlation Research in the Public Interest, Luglio 2025 (134.2 KB)
259
, The Discrepancy Between the Number of Saved Lives with COVID-19 Vaccination and Statistics of Our World Data. Journal of Clinical Trials, Marzo 2025 (450 KB)
260
Eccesso di mortalità in Europa nel post-Covid. EUROSTAT
261
, Mortalità totale in eccesso anni 2021 e 2022 - Dati ufficiali dall’Italia e dal mondo. 7 Aprile 2023 (1.6 MB)
262
, Risposta al report del 07/04/2023 dell’Associazione Umanità e Ragione. (682.9 KB)
263
, Controrisposta ad ISS. 9 Febbraio 2024 (1.1 MB)
264
, Mortalità totale in eccesso in Italia anni 2021, 2022 e I semestre 2023. 18 Marzo 2024 (601.7 KB)
265
et alias, Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida. MedRxiv (studio in pre-print), 2025 (1 MB)
266
et alias, Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022. The British Medical Journal Public Health, 2024 (1.9 MB)
267
, et alias, Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington. Journal of Emergency Medicine: Open Access, Ottobre 2024 (901 KB)
268
et alias, Paradoxical increase in gloal Covid-19 deathswith vaccination coverage: WHO estimates(2020-2023). International Journal of Risk and safety in Medicine, 2025
269
, The Rollout of COVID-19 Booster Vaccines is Associated With Rising Excess Mortality in New Zealand. University of Wakaito, Working Paper in Economics, Novembre 2022 (340.1 KB)
270
et alias, Age-stratified COVID-19 vaccine-dose fatality rate for Israel and Australia. Correlation Research in the Public Interest, Febbraio 2023 (1.5 MB)
271
et alias, COVID-19 vaccine-associated mortality in the Southern Hemisphere. Journal of Research and Applied Medicine, Settembre 2023 (8.7 MB)
272
et alias, Spatiotemporal variation of excess all-cause mortality in the world (125 countries) during the Covid period 2020-2023 regarding socio-economic factors and public-health and medical interventions. Correlation Research in the Public Interest, 19 Luglio 2024
273
, Probable causal association between India’s extraordinary April-July 2021 excess-mortality event and the vaccine rollout. Correlation Research in the Public Interest, 6 Dicembre 2022 (615.8 KB)
274
et alias, Probable causal association between Australia’s new regime of high all-cause mortality and its COVID-19 vaccine rollout. Correlation Research in the Public Interest, Dicembre 2022 (3.5 MB)
275
, et alias, Compound Impacts of COVID-19 mRNA Vaccination and SARS-CoV-2 Infection: A Convergence of Diverse “Spikeopathies” and Other Hybrid Harms. European Society of Medicine, Novembre 2025 (807.5 KB)
276
, Rapporto annuale sulla sicurezza dei vaccini anti Covid-19, periodo 27/12/2020 - 26/12/2021. (8.4 MB)
277
, Articolo su Francesca Tuscano. (95.1 KB)
278
, , , The WHO Algorithm for Causality Assessment of Adverse
Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement. Journal of Clinical Medicine, Novembre 2024 (1.8 MB)
279
, , Serious harms of the COVID-19 vaccines: a systematic review. MedRxiv (studio in pre-print), 2023 (378.5 KB)
280
, Rapporto N.14 sulla sorveglianza dei vaccini anti Covid-19, periodo 27/12/2020 - 26/12/2022. (6.5 MB)
281
, Numero totale di dosi somministrate in Europa.
282
, Perizia firmata e timbrata - Documento di sintesi segnalazioni effetti avversi vaccini Covid-19 presenti nella banca dati EudraVigilance, periodo dal 27/12/2020 al 27/12/2025. (2.2 MB)
283
et alias, Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database. Nature, 2025 (4.6 MB)
284
et alias, Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data. Expert Review of Vaccines, Gennaio 2025 (486.2 KB)
285
et alias, Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events. Epidemiology and Health, Luglio 2023 (299.9 KB)
286
et alias, Transient elevation of NT-proBNP after mRNA COVID-19 vaccination in healthy adults: A longitudinal biomarker analysis. Vaccine, Marzo 2026 (721.5 KB)
287
, Millions Experienced COVID-19 Vaccine Side Effects.
288
, Ignored dangers of the COVID-19 injections. Surgical Neurology International, Novembre 2023 (168.7 KB)
289
, , , Review: Calls for Market Removal of COVID-19 Vaccines Intensify as Risks Far Outweigh Theoretical Benefits. Science, Public Health Policy and the Law, Gennaio 2025 (1.6 MB)
290a
, Ritiro dal mercato vaccino VaxZevria di Astrazeneca. 27 Marzo 2024 (117.1 KB)
290b
, Ritiro dal mercato vaccino Jcovden di Janssen. 26 Luglio 2024 (126.8 KB)
291
, The Potential of Extracellular Vesicle-Mediated Spread of Self-Amplifying RNA and a Way to Mitigate It. International Journal of Molecular Science, Maggio 2025 (439.5 KB)
Cap 3.5
292
et alias, Covid-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy! Journal of Clinical Medicine, Aprile 2020 (187 KB)
293
, et alias, No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science. Journal of Clinical Medicine, Giugno 2020 (1.3 MB)
294
et alias, Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet, Giugno 2020 (2.8 MB)
295
et alias, Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs binding to ACE2. Frontiers in immunology, Gennaio 2026 (6.6 MB)
296
International Covid Summit - Intervento del dott. Andrea Stramezzi al parlamento UE di Bruxelles. 3 Maggio 2023
297
et alias, Multifaceted highly targeted sequential multidrug treatment of early
ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in Cardiovascular Medicine, Dicembre 2020 (773.4 KB)
298
, Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS CoV-2 Infection. The American Journal of Medicine, 2021 (783.1 KB)
299
, et alias, A recurrent question from a primary care physician: How should I treat my COVID-19 patients at home? An update. Clinical and Medical Investigations, Novembre 2020 (403 KB)
300
et alias, Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity. Frontiers in Nutrition, Novembre 2020 (805.3 KB)
301
et alias, Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition, Giugno 2020 (357.8 KB)
302
Sito web dell'Independent Medical Alliace.
303
, I-CARE. Early Covid Treatment. Febbraio 2024 (407.9 KB)
304
et alias, Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clinical Immunology, Giugno 2020 (1.2 MB)
305
et alias, Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. Hypotheses, Giugno 2020 (319.5 KB)
306
, , N-Acetylcysteine to Combat COVID-19: An Evidence Review. Therapeutics and Clinical Risk Management, Dicembre 2021 (1.2 MB)
307
et alias, Calming the cytokine storm in COVID-19. Nature Medicine, Settembre 2021 (6.3 MB)
308
, , et alias, Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021. Clinial Research, 2021 (349.3 KB)
309
et alias, The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure? Journal of Pharmacy and Pharmacology Research, Maggio 2023 (512.5 KB)
310
, et alias, A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study. Eclinical Medicine, 2021 (730.3 KB)
311
et alias, Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial. Haematologica, 2020 (379.9 KB)
312
et alias, Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews. Diagnostics, Settembre 2021 (1.5 MB)
313
et alias, A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. Journal of Clinical Investigation, 2021 (454.7 KB)
314
et alias, Convalescent Plasma for Covid-19 Induced ARDS in Mechanically Ventilated Patients. The New England Journal of Medicine, Ottobre 2023 (558.7 KB)
315
et alias, Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial. JAMA Network Open, Novembre 2021 (1 MB)
316
, Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, Maggio 2021 (957.9 KB)
317
et alias, Convalescent plasma for people with COVID-19: a living systematic review (Review). Cochrane Library, 2024 (3.7 MB)
318
, COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A systematicReview and Meta-analysis. JAMA Network Open, 2023 (1.3 MB)
319
et alias, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, Agosto 2025 (847.8 KB)
320
, , Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 2020 (1.2 MB)
321
Hydroxychloroquine reduces COVID-19 risk: real-time meta analysis of 424 studies (c19hcq hcqmeta). c19early.com, Novembre 2025 (2.8 MB)
322
, Repurposed Antiviral Drugs for Covid-19 - Interim WHO
Solidarity Trial Results. The New England Journal of Medicine, Febbraio 2021 (688.2 KB)
323
, Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. The New England Journal of Medicine, Agosto 2021 (625.3 KB)
324
et alias, Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nature Communications, 2021 (1.6 MB)
325
, Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. European Journal of Internal Medicine, 2020 (811.1 KB)
326
, et alias, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, Maggio 2020 (1 MB)
327
, Safety of Ivermectin. (196.4 KB)
328
et alias, Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacological Research, Settembre 2020 (2.9 MB)
329
, Raccomandazione sull'ivermectina N.153588/2021. 22 Marzo 2021 (146.3 KB)
330
et alias, Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use? Signa Vitae, Aprile 2021 (241.7 KB)
331
et alias, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, Aprile 2020 (443.7 KB)
332
, Ivermectin reduces COVID-19 risk: realtime meta analysis of 106 studies (c19ivmivmmeta). Novembre 2025 (3.7 MB)
333
, Protocollo profilassi e trattamento per Covid-19 I-MASK+. (504.6 KB)
334
et alias, The mechanisms of action of ivermectin against SARS-CoV-2 - an extensive review. The Journal of Antibiotics, 2021 (1.7 MB)
335
et alias, Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, Marzo 2021 (1 MB)
336
et alias, Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. American Journal of Therapeutics, 2021 (975.5 KB)
337
et alias, Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. American Journal of Therapeutics, 2021 (3.2 MB)
338
et alias, Covid-19: The Ivermectin African Enigma. Colombia medica, Dicembre 2020 (590.9 KB)
339
et alias, Why COVID-19 is not so spread in Africa: How does Ivermectin affect it? MedRxiv (studio in pre-print) (58.1 KB)
340
, The Publication of Fraudulent Ivermectin Trials by the High Impact Medical Journals.
341
et alias, Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA, 2021 (361.8 KB)
342
Ivermectin for preventing and treating COVID-19 (Review). Cochrane Library, 2024 (1.8 MB)
343
et alias, Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Articolo accettato, 2021 (3.3 MB)
344
et alias, RETRACTED: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection. Open Forum Infectious Diseases, 2021 (3.7 MB)
346
et alias, Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud. Open Forum Infectious Diseases, 2022 (234.5 KB)
345
Conversazione via zoom tra Tess Lawrie ed Andrew Hill in merito alle pubblicazioni di Hill sull'ivermectina.
Cap 3.6
347
et alias, Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19. The Journal of Clinical Investigation, 2023 (915 KB)
348
et alias, Fever and the thermal regulation of immunity: the immune system feels the heat. Nature Reviews Immunology, 2015 (2.2 MB)
349
et alias, The Effect of Antipyretic Therapy upon Outcomes in Critically Ill Patients: A Randomized, Prospective Study. Surgical Infection, 2005 (149.8 KB)
350
et alias, Clinical review: Fever in intensive care unit patients. Critical Care, Giugno 2003 (55.7 KB)
351
, Population-level effects of suppressing fever. Proceedings of the Royal Society, Gennaio 2024 (770.3 KB)
352
, Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infectious Diseases, 2020 (1.8 MB)
353
, , Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Frontiers in Pharmacology, Ottobre 2020 (588.6 KB)
354
et alias, Paracetamol in the home treatment of early COVID‐19 symptoms: A possible foe rather than a friend for elderly patients? Journal of Medical Virology, 2021 (710 KB)
355
, , Could glutathione depletion be the Trojan horse of COVID-19 mortality? European Review for Medical and Pharmacological Sciences, 2020 (717.5 KB)
356
, Circolare Prot. 0024970 - Gestione domiciliare dei pazienti con infezione da SARS-CoV-2. 30 Novembre 2020 (1.2 MB)
357
, Confronto tra i vari trattamenti anti Covid per costo ed efficacia.
358
, Remdesivir for COVID-19: real-time meta analysis of 82 studies. Novembre 2025 (1.6 MB)
359
, Parere negativo sull'autorizzazione all'immissione in commercio di Lagevrio (molnupiravir). 24 Febbraio 2023 (68.6 KB)
360
et alias, Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments. The Journal of Clinical Investigation, Marzo 2023 (1.4 MB)
361
, Parere su anticorpi monoclonali. 4 Febbraio 2021 (646.9 KB)
Cap 3.7
362
, , Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19. International Journal of Vaccine Theory, Practice, and Research, Maggio 2021 (738.2 KB)
363
et alias, Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning. Nature Biotechnology, Gennaio 2025 (9.6 MB)
364
, Chemical-Physical Criticality and Toxicological Potential of Lipid Nanomaterials Contained in a COVID-19 mRNA Vaccine. International Journal of Vaccine Theory, Practice, and Research, Gennaio 2023 (4.3 MB)
365
, Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation. Clinical Immunology, Aprile 2021 (374.5 KB)
366
et alias, Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. Journal of Allergy and Clinical Immunology, Dicembre 2016 (909.2 KB)
367
, et alias, Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability. The American Society of Gene Therapy, Settembre 2008 (1000 KB)
368
et alias, N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature, Gennaio 2024
369
et alias, Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer? International Journal of Biological Macromolecules, Aprile 2024 (4 MB)
370
et alias, Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Nature, Aprile 2022 (4.4 MB)
371
et alias, PUS1 promotes hepatocellular carcinoma via mRNA pseudouridylation to enhance the translation of oncogenic mRNAs. American Association for the Study of Liver Diseases, 2023 (4 MB)
372
et alias, Pseudouridylation-Related Genes Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma Patients. Journal of Cancer, 2025, Vol.16 (8.2 MB)
373
et alias, Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada. Autoimmunity, 2025, Vol.58 (8.6 MB)
374
et alias, Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends in Molecular Medicine, Luglio 2022 (2 MB)
375
, , , Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines. Biomedicines, Febbraio 2023 (5.1 MB)
376
, “Spikeopathy”: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA. Biomedicines, Agosto 2023 (6.8 MB)
377
, et alias, Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food and Chemical Toxicology, Aprile 2022 (910.5 KB)
378
et alias, Adenovirus-induced thrombocytopenia: the role of vonWillebrand factor and P-selectin in mediating accelerated platelet clearance. Blood, Aprile 2007 (296.1 KB)
379
et alias, ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science Advances, Gennaio 2021 (1.3 MB)
380
, Aclaración al informe preliminar sobre la presencia de grafeno en vacuna mRna Comirnaty. 23 Luglio 2021 (4.6 MB)
381
, Detección de oxido de grafeno en suspención acuosa – estudio observacional en microscopia óptica y electrónica. 22 Agosto 2021 (7.5 MB)
382
, , , et alias, COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. International Journal of Vaccine Theory, Practice, and Research, Agosto 2024 (2 MB)
383
, et alias, COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine, Febbraio 2024 (3.5 MB)
384
, Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 2021 (3.6 MB)
385
et alias, New-onset psychosis following COVID-19 vaccination: a systematic review. Frontiers in Psychiatry, Aprile 2024 (914.5 KB)
386
, et alias, Association Between COVID-19 Vaccination and Neuropsychiatric Conditions. International Journal of Innovative Research in Medical Science (IJIRMS), Giugno 2025 (422.9 KB)
387
, , Breaking the silence: Recognizing post-vaccination syndrome. Heliyon, Giugno 2025 (3.1 MB)
388
, et alias, Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study. Biomedicines, Dicembre 2024 (852.2 KB)
389
et alias, Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review. Journal of Clinical Neuroscience, Agosto 2022 (1.2 MB)
390
et alias, Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Revue Neurologique, Gennaio 2023 (1.1 MB)
391
et alias, COVID-19 mRNA vaccine may trigger subacute thyroiditis. Human Vaccines & Immunotherapeutics, Dicembre 2021 (3.6 MB)
392
et alias, Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA‑based SARS‑CoV2 vaccination: from Graves’ disease to silent thyroiditis. Journal of Endocrinological Investigation, Novembre 2021 (671.8 KB)
393a
, , SARS-CoV-2 vaccines are not free of neurological side effects. Acta Neurologica Scandinavia, Aprile 2021 (189.8 KB)
393b
, Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurologica Scandinavia, Ottobre 2021 (346.3 KB)
394
, Neurological Adverse Reactions to SARS-CoV-2 Vaccines. Clinical Psychopharmacology and Neuroscience, Febbraio 2023 (1.6 MB)
395
et alias, Small Fiber Neuropathy Associated With the Moderna SARS-CoV-2 Vaccine. Cureus, Giugno 2022 (75.5 KB)
396
, , , SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis. Clinics, 78/2023 (131.7 KB)
397
et alias, Post COVID-19 vaccine small fiber neuropathy. Muscle & Nerve, 2021 (320.5 KB)
398
et alias, Small fiber neuropathy following COVID-19 vaccination: A case series. Journal of the Neurological Sciences, Maggio 2025 (449.4 KB)
399
et alias, Herpes zoster and alopecia areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects. Journal of Cosmetic Dermatology, 2023 (1.2 MB)
400
et alias, COVID-19 vaccine-induced Stevens–Johnson syndrome. Clinical and Experimental Dermatology, 2021 (999.8 KB)
401
et alias, Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers. Vaccines, Ottobre 2023 (1.9 MB)
402
, et alias, Postural orthostatic tachycardia syndrome is the most frequent cardiovascular autonomic disorder following COVID‑19 infection or vaccination. Journal of Neurology, Novembre 2025 (4.7 MB)
403
et alias, Association Between COVID‐19 Vaccination and Gastrointestinal Manifestations: A Cross‐Sectional Study. Health Science Reports, Luglio 2025 (325.4 KB)
404
et alias, Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and mRna-1273 COVID-19 Vaccines in 3 Nordic Countries. JAMA Network Open, Giugno 2022 (821.8 KB)
405
et alias, COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes. International Journal of Innovative Research in Medical Science (IJIRMS), Novembre 2024 (350.6 KB)
406
, Historical Reference of Seasonal Influenza Vaccine Doses Distributed.
407
et alias, Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, Marzo 2022 (1.3 MB)
408
et alias, Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview. Cardiology and Therapy, Novembre 2021 (270.7 KB)
409
et alias, The Association of SARS-CoV-2 Infection and COVID-19 Vaccination With Sudden Death: An Explorative Review. Cureus, Agosto 2025 (2.4 MB)
410
et alias, Clinical Presentation and Outcomes of Myocarditis Post mRNA Vaccination: A Meta-Analysis and Systematic Review. Cureus, Novembre 2021 (379.7 KB)
411
et alias, Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine, Febbraio 2022 (3.1 MB)
412
, Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings. Cureus, Agosto 2022 (665.7 KB)
413
, , Risk stratification for future cardiac arrest after COVID-19 vaccination. World Journal of Cardiology, Febbraio 2025 (6.4 MB)
414
et alias, Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. The New England Journal of Medicine, Dicembre 2021 (386.1 KB)
415
et alias, Increased emergency cardiovascular events among under‑40 population in Israel during vaccine rollout and third COVID‑19 wave. Nature, Aprile 2022 (2.7 MB)
416
et alias, Trends in ambulatory cardiology consultations for suspected myocarditis after COVID‑19 vaccination. Clinical Research in Cardiology, Novembre 2021 (538.1 KB)
417
et alias, SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiology, Aprile 2022 (508.5 KB)
418
et alias, Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination. European Journal of Heart Failure, Agosto 2023 (1.4 MB)
419
et alias, Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Tropical Medicine and Infectious Disease, Agosto 2022 (1.1 MB)
420
Il dott. Barbaro mostra i suoi dati sulle cardiopatie a Radio Radio TV.
421
et alias, Immune and hematologicak responses to the third dose of an mRNA COVID-19 vaccine: a six-month longitudinal study. Frontiers in Cellular and Infection Microbiology, Luglio 2025 (554.9 KB)
422
et alias, FIFA Sudden Death Registry (FIFA-SDR): a prospective, observational study of sudden death in worldwide football from 2014 to 2018. British Journal of Sports Medicine, Dicembre 2020 (747.8 KB)
423
et alias, Sudden cardiac death in athletes: A 20-year analysis in Portugal. Portuguese Journal of Cardiology, Ottobre 2024 (552.3 KB)
424
Troppi malori improvvisi tra i giovani, uno studio rivela la causa. 21 Luglio 2022
425
Il prof. Alessandro Capucci si espone sui vaccini ad mRna e nega l'esistenza di miocarditi lievi e "benigne".
426
, Invito alla vaccinazione pediatrica - prot. 2021/0218683/P. 6 Agosto 2021 (1 MB)
427
et alias, 10-year survival outcome after clinically suspected acute myocarditis in adults: A nationwide study in the pre-COVID-19 era. PloS ONE, Gennaio 2023 (1.1 MB)
428
et alias, Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study. The Lancet, Ottobre 2024 (1.8 MB)
429
et alias, Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiology, Agosto 2021 (266.3 KB)
430
et alias, COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, Novembre 2021 (4 MB)
431
et alias, Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males – Case reports. Vaccine: X, Maggio 2023 (1 MB)
432
, COVID-19 vaccine: Strong association with cardiovascular death, especially hemorrhagic stroke and venous thrombosis. Med Check, 08-12/2021/Vol.7 N. 21-22 (3.8 MB)
433
, et alias, Autopsy‑based histopathological characterization of myocarditis after anti‑SARS‑CoV‑2‑vaccination. Clinical Research in Cardiology, Novembre 2022 (2.5 MB)
434
et alias, Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. Journal of Korean Medical Science (JKMS), Ottobre 2021 (5.7 MB)
435
et alias, Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, Dicembre 2021 (940 KB)
436a
, et alias, WITHDRAWN: A systematic review of autopsy findings in deaths after COVID-19 vaccination. (24.9 KB)
436b
, et alias, Autopsy findings in cases of fatal COVID-19 vaccine induced myocarditis. ESC Heart Failure, Gennaio 2024 (1.7 MB)
437
, , COVID-19 mRNA-Induced "Turbo Cancers". Journal of Independent Medicine, 2025, Vol. 1 - N. 3 (980.3 KB)
438
et alias, Covid-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an italian province. EXCLY Journal, Luglio 2025 (875.1 KB)
439
, , COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms. Oncotarget, Gennaio 2026 (5.2 MB)
440
et alias, 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea. Biomarker Research, Settembre 2025 (1.1 MB)
441
et alias, RETRACTED: Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus, Giugno 2024 (1.1 MB)
442
et alias, Menstrual disorders following COVID-19 vaccination: a review using a systematic search. Frontiers in Drug Safety and Regulation, Gennaio 2024 (887.8 KB)
443
, et alias, Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey. Open Medicine, 2022, Vol.17 (376.6 KB)
444
et alias, Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women. Science Advances, Settembre 2023 (4.6 MB)
445
et alias, The effects of Covid‑19 mRNA vaccine on adolescence gynecological well‑being. Gynecologic Endocrinology and Reproductive Medicine, Marzo 2023 (664.5 KB)
446
et alias, The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities. Vaccines, Giugno 2024 (920.5 KB)
447
et alias, Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. Vaccines, Marzo 2025 (6.2 MB)
448
et alias, Comparison of sperm parameters and DNA fragmentation index between infertile men with infection and vaccines of COVID-19. Asian Journal of Andrology, Aprile 2023 (800.1 KB)
449
, , Fertility declines near the end of the COVID-19 pandemic: Evidence of the 2022 birth declines in Germany and Sweden. Stockholm Research Reports in Demography, 2022, N.17 (756.5 KB)
450
et alias, Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic. International Journal of Risk and safety in Medicine, 2025, Vol.36 (666.6 KB)
451
, Aggiornamento sul periodo di validità del vaccino a mRNA anti-COVID-19 (modificato a livello dei nucleosidi). 7 Agosto 2023 (167.2 KB)
452
, AIFA – Sospensione somministrazione vaccino COVID-19 ASTRA ZENECA. Circ. 12881 Prot. 202100002705/A.G. 11 Marzo 2021 (493 KB)
453
et alias, Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. European Journal of Clinical Investigation, 2023 (116.1 KB)
454
, Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes. Journal of American Physicians and Surgeons, 2023, Vol.28 (1.9 MB)
455
, Protocollo I-Prevent per danni da vaccino - Parte A. Aprile 2023 (83.8 KB)
456
, Protocollo I-Prevent per danni da vaccino - Parte B. Aprile 2023 (400.4 KB)
457
, Covid-19: politicisation, “corruption,” and suppression of science. The British Medical Journal, Novembre 2020 (297.6 KB)
PARTE IV
458b
, Post del blog viaggiepianoforte sul selous Game Reserve.
458a
, Post del blog viaggiepianoforte sul Kilimangiaro.
459
, Stefano Cipolloni suona il brano di Ezio Bosso "Following a bird".
460
, Post del blog viaggiepianoforte.it sul "Pibe de oro" Diego Armando Maradona.
461
, Post del blog viaggiepianoforte sul viaggio in camper della famiglia Cipolloni nel 2020.
462
, Stefano Cipolloni suona di fronte di fronte il castello Eilean Donen in Scozia.
463a
, Post del blog viaggiepianoforte sul trekking dell'Everest - Parte A.
463b
, Post del blog viaggiepianoforte sul trekking dell'Everest - Parte B.
464
et alias, The COVID-19 Pandemic Increased the Risk of Eating Disorders and Emotional Eating Symptoms: A Review of the Current Clinical Evidence. MDPI-COVID, Ottobre 2024 (807.6 KB)
465
Saggio danza di Maya - estate 2022.
466
Pagina web della psicologa Gabriela Osorio.
467
, Post del blog viaggiepianoforte su Gabriela Osorio.
468
, Post del blog viaggiepianoforte sull'Isola di Pasqua.
469
, Post del blog viaggiepianoforte sulla Linea Sacra di San Michele.
470a
, Post del blog viaggiepianoforte su Guanajuato.
470b
, Post del blog viaggiepianoforte su Guanajuato ed il matrimonio di Stefano e Gaby.
471
Video ufficiale del pellegrinaggio Parigi-Chartres.
472
Don Guilherme Peixoto alla GMG di Lisbona.